tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

INSM Stock Latest News

3 Best Stocks to Buy Now, 9/11/2024, According to Top Analysts 
Market News3 Best Stocks to Buy Now, 9/11/2024, According to Top Analysts 
9d ago
INSM
ROIV
Boehringer data has positive read-through to Insmed, says Barclays
PremiumThe Fly
Boehringer data has positive read-through to Insmed, says Barclays
9d ago
INSM
Boehringer Ingelheim’s AIRLEAF data reads well for Insmed, says Stifel
PremiumThe Fly
Boehringer Ingelheim’s AIRLEAF data reads well for Insmed, says Stifel
9d ago
INSM
Insmed added to Americas Conviction List at Goldman Sachs
PremiumThe Fly
Insmed added to Americas Conviction List at Goldman Sachs
17d ago
INSM
Insmed price target raised to $85 from $77 at Wells Fargo
PremiumThe Fly
Insmed price target raised to $85 from $77 at Wells Fargo
1M ago
INSM
Insmed price target raised to $98 from $75 at TD Cowen
PremiumThe FlyInsmed price target raised to $98 from $75 at TD Cowen
1M ago
INSM
Insmed backs 2024 global Arikayce revenues view up 15% to $340M-$360M
Premium
The Fly
Insmed backs 2024 global Arikayce revenues view up 15% to $340M-$360M
1M ago
INSM
Insmed reports Q2 EPS ($1.94), consensus ($1.27)
Premium
The Fly
Insmed reports Q2 EPS ($1.94), consensus ($1.27)
1M ago
INSM
Insmed Reports Second-Quarter 2024 Financial Results and Provides Business Update
PremiumPress Releases
Insmed Reports Second-Quarter 2024 Financial Results and Provides Business Update
1M ago
INSM
Is INSM a Buy, Before Earnings?
PremiumPre-Earnings
Is INSM a Buy, Before Earnings?
1M ago
INSM
Insmed price target raised to $85 from $60 at Morgan Stanley
PremiumThe Fly
Insmed price target raised to $85 from $60 at Morgan Stanley
2M ago
INSM
Insmed’s (NASDAQ:INSM) Potentially Groundbreaking Drug
PremiumMarket News
Insmed’s (NASDAQ:INSM) Potentially Groundbreaking Drug
2M ago
INSM
Insmed price target raised to $95 from $70 at Guggenheim
PremiumThe FlyInsmed price target raised to $95 from $70 at Guggenheim
2M ago
INSM
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
INSM
MDWD
Insmed price target raised to $90 from $70 at H.C. Wainwright
Premium
The Fly
Insmed price target raised to $90 from $70 at H.C. Wainwright
2M ago
INSM
Insmed ASPEN data received ‘overwhelmingly positive reception,’ says BofA
PremiumThe Fly
Insmed ASPEN data received ‘overwhelmingly positive reception,’ says BofA
3M ago
INSM
Insmed reports inducement grants under NASDAQ listing rule
PremiumThe Fly
Insmed reports inducement grants under NASDAQ listing rule
3M ago
INSM
Insmed Reveals Promising Brensocatib Study Results
PremiumCompany Announcements
Insmed Reveals Promising Brensocatib Study Results
3M ago
8K
INSM
Insmed announces additional results from ASPEN study of brensocatib
PremiumThe Fly
Insmed announces additional results from ASPEN study of brensocatib
3M ago
INSM
Insmed put volume heavy and directionally bearish
PremiumThe FlyInsmed put volume heavy and directionally bearish
3M ago
INSM
Insmed price target raised to $88 from $68 at Truist
Premium
The Fly
Insmed price target raised to $88 from $68 at Truist
3M ago
INSM
Insmed price target raised to $83 from $62 at BofA
Premium
The Fly
Insmed price target raised to $83 from $62 at BofA
3M ago
INSM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >